Goldman Sachs’s Select Medical SEM Stock Holding History

Goldman Sachs’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-12,064	Closed	-$112K	–	5977
2018 Q1	$112K	Sell	12,064 -7,981	-40%	-$76K	﹤0.01%	5242
2017 Q4	$191K	Buy	+20,045	New	+$192K	﹤0.01%	5450
2017 Q1	–	Sell	-2,784	Closed	-$20K	–	6979
2016 Q4	$20K	Buy	2,784 +2,413	+650%	+$16.8K	﹤0.01%	6647
2016 Q3	$3K	Sell	371 -1,856	-83%	-$11.8K	﹤0.01%	6948
2016 Q2	$13K	Buy	+2,227	New	+$14.8K	﹤0.01%	6820
2015 Q3	–	Sell	-15,405	Closed	-$134K	–	7470
2015 Q2	$134K	Buy	15,405 +4,455	+41%	+$37.4K	﹤0.01%	6444
2015 Q1	$87K	Buy	10,950 +8,723	+392%	+$65.2K	﹤0.01%	6489
2014 Q4	$17K	Buy	+2,227	New	+$16.2K	﹤0.01%	7002
2014 Q3	–	Sell	-2,227	Closed	-$19K	–	7238
2014 Q2	$19K	Sell	2,227 -444,327	-100%	-$3.44M	﹤0.01%	6886
2014 Q1	$3M	Hold	446,554	–	–	﹤0.01%	3583
2013 Q4	$2.79M	Buy	+446,554	New	+$2.18M	﹤0.01%	3722

Other funds holding SEM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Goldman Sachs's SEM Position: Q1 2026 in Review

Goldman Sachs increased its Select Medical (SEM) stake by 319% in Q1 2026, buying an estimated $24.8M and bringing the position to 2,081,883 shares worth $33.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1925.

Goldman Sachs first reported a position in SEM in Q2 2013 and has held it in 52 quarters since. The position peaked at $80.5M in Q2 2021. 277 funds tracked by Wall St. Rank hold SEM as of Q1 2026.

Goldman Sachs held 2,081,883 shares of Select Medical worth $33.9M as of Q1 2026.
Goldman Sachs bought 1,585,237 Select Medical shares in Q1 2026, an estimated $24.8M.
Select Medical made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #1925 holding.
Goldman Sachs first reported a position in Select Medical in Q2 2013 and has held it in 52 quarters since.
Goldman Sachs's Select Medical position peaked at $80.5M in Q2 2021.
277 funds tracked by Wall St. Rank held Select Medical as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.